"Access to Information" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Individual's rights to obtain and use information collected or generated by others.
| Descriptor ID |
D022126
|
| MeSH Number(s) |
I01.880.604.473.352.500.030 L01.143.024 L01.737.030
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Access to Information".
Below are MeSH descriptors whose meaning is more specific than "Access to Information".
This graph shows the total number of publications written about "Access to Information" by people in this website by year, and whether "Access to Information" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 2 | 4 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 3 | 3 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 2 | 3 |
| 2019 | 2 | 1 | 3 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Access to Information" by people in Profiles.
-
eHealth patient-provider communication in the United States: interest, inequalities, and predictors. J Am Med Inform Assoc. 2017 Apr 01; 24(e1):e18-e27.
-
Improving the effectiveness of electronic health record-based referral processes. BMC Med Inform Decis Mak. 2012 Sep 13; 12:107.
-
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res. 2010 Jan; 38(Database issue):D652-7.
-
Social networkers' attitudes toward direct-to-consumer personal genome testing. Am J Bioeth. 2009; 9(6-7):3-10.
-
Ethical issues arising when interim data in clinical trials is restricted to independent data monitoring committees. IRB. 2000 Jan; 22(1):7-11.